ECS vs PHX

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

ECS

ECSBOTANIC FPO [ECS]

50MEDIUM

PHX

PHARMX FPO [PHX]

42LOW

Score Breakdown

ECS PHX
Technical
33
57
Catalyst
53
51
Sentiment
50
50
Fundamental
61
66
Momentum
53
55
Risk Gate
27
50

Key Metrics

ECS Metric PHX
$8.0MMarket Cap$79.1M
1.4MAvg Volume (20d)448K
N/AShort InterestN/A
$0.01052-Week High$0.200
$0.00352-Week Low$0.084
-20.0%Daily Change+0.0%
$0.004Reference Price$0.120
N/AROE-5.9%
N/AProfit Margin-12.2%

Active Signals

ECS Signals

●RSI drifting toward oversold territory — worth watching
●Stochastic turning bearish from a high level — caution
●Trading below both moving averages — the trend is working against this one
●Took a hit — down 20.0% over the last 5 days
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (16 quarters)
●Very high P/S ratio (2211.4x)

PHX Signals

●Beating the Small Ords index — relative strength of 1.12, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Moderate P/S ratio (10.3x)
●Small-cap ($20-100M)
●Capital raise activity (1 events)
●CANSLIM S: Tight float (41%)
●Negative profit margins (-12%)

Ask Scout AI to compare ECS and PHX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

ECS vs RAC →ECS vs TRI →ECS vs TRU →EIQ vs EZZ →EIQ vs HMD →
ECS Full Analysis → PHX Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).